Content about Collaborative Care

December 7, 2012

The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.

PITTSBURGH — The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.

Mylan announced the approval and launch of candesartan cilexetil and hydrochlorothiazide tablets in the 16/12.5-mg, 32/12.5-mg and 32/25-mg strengths. Mylan said it was the first company to submit a complete regulatory approval application for the drug and is thus entitled to 180 days of market exclusivity in which to compete directly with the branded version.

December 6, 2012

Pharmacy benefit manager Catamaran Corp. has opened a new "Center of Excellence" in downtown Indianapolis, the company said Thursday.

LISLE, Ill. — Pharmacy benefit manager Catamaran Corp. has opened a new "Center of Excellence" in downtown Indianapolis, the company said Thursday.

Catamaran announced the opening of the 13,000-square-foot center, which it said will support the services it will provide under the $60 million, six-year Medicaid contract with the Indiana state government, signed in October.

December 6, 2012

The Food and Drug Administration has given special designation to a treatment made by Biodel for patients with congenital hyperinsulinism, a rare disorder that affects children.

DANBURY, Conn. — The Food and Drug Administration has given special designation to a treatment made by Biodel for patients with congenital hyperinsulinism, a rare disorder that affects children.

Biodel announced that it had received orphan drug designation for glucagon to prevent hypoglycemia, or abnormally low blood sugar, in patients with CHI.

December 6, 2012

Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat active psoriatic arthritis, the company said Thursday.

HORSHAM, Pa. — Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat active psoriatic arthritis, the company said Thursday.

J&J subsidiary Janssen Biotech submitted an application to the FDA for Stelara (ustekinumab) for adult patients with the disease, which affects more than 2 million people in the United States, according to the National Psoriasis Foundation. Another subsidiary is seeking approval for Stelara for the same usage in Europe.

December 6, 2012

Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.

WOODCLIFF LAKE, N.J. — Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.

Par announced that it had entered a supply and distribution agreement through subsidiary Par Pharmaceutical to distribute an authorized generic version of Atacand HCT (i.e., candesartan cilexetil and hydrochlorothiazide) tablets.

An authorized generic is a branded drug marketed under its generic name at a discounted price, usually through a third-party company.

December 6, 2012

Retail pharmacy chain Rite Aid will deliver patients' immunization notifications directly to healthcare providers over the Surescripts Network for Clinical Interoperability.

ARLINGTON, Va. — Retail pharmacy chain Rite Aid will deliver patients' immunization notifications directly to healthcare providers over the Surescripts Network for Clinical Interoperability.

December 5, 2012

Drug maker Novo Nordisk is creating what it calls the world's first all-diabetes professional cycling team, the company said.

BAGSVÆRD, Denmark — Drug maker Novo Nordisk is creating what it calls the world's first all-diabetes professional cycling team, the company said.

The Danish pharmaceutical manufacturer announced plans to create Team Novo Nordisk, a global team with more than 100 cyclists, triathletes and runners, all of whom have diabetes.

December 5, 2012

A network of pharmacies formed with the goal of helping patients achieve better health outcomes while reducing costs has appointed a new executive to its leadership team.

LEESBURG, Va. — A network of pharmacies formed with the goal of helping patients achieve better health outcomes while reducing costs has appointed a new executive to its leadership team.

RxAlly announced the appointment of Rebecca Chater as VP health outcomes. Chater, a pharmacist who has worked in clinical services for 20 years, will be responsible for providing leadership and clinical management of RxAlly solutions and integrating business development with clinical staff and operations.

December 4, 2012

Hiding tobacco product displays at the point of sale may help reduce smoking among young people, a new study suggests.

RESEARCH TRIANGLE PARK, N.C. — Hiding tobacco product displays at the point of sale may help reduce smoking among young people, a new study suggests.

The study, conducted by RTI International and Tarheel Technologies and published in the January 2013 issue of the journal Pediatrics, examined the behaviors of more than 1,200 smokers and likely smokers ages 13 years to 17 years in a virtual convenience store in which tobacco products were either hidden behind a cabinet or openly displayed along with tobacco ads.

December 4, 2012

The Food and Drug Administration will review an acid-reflux drug made by Eisai for use in children, the drug maker said.

WOODCLIFF LAKE, N.J. — The Food and Drug Administration will review an acid-reflux drug made by Eisai for use in children, the drug maker said.

Eisai said the FDA accepted its application for AcipHex delayed-release sprinkle capsules in the 5-mg and 10-mg strengths for healing of gastroesophageal reflux disease, and maintenance of healing of GERD and improvement of symptoms in children ages 1 year to 11 years.

The FDA expects to have the application reviewed by March 27, 2013. The drug is currently approved in the 20-mg strength for adolescents and adults.

December 4, 2012

The number of consumers using iPhones to gather medical information has grown by 94% since 2011, according to a new study by online medical publishing company The Patient's Guide.

IRVINE, Calif. — The number of consumers using iPhones to gather medical information has grown by 94% since 2011, according to a new study by online medical publishing company The Patient's Guide.

The study, based on engagement-behavior data on 12 million visitors to the site over two years, also found that the iPhone topped the list of mobile devices used to seek medical information online, accounting for 41% of total mobile traffic this year; the company predicts that the iPhone will surpass the desktop computer as the primary device for health information by 2014.

December 4, 2012

Pharmacy technology provider QS/1 has entered a contract with CoverMyMeds to automate a process often required by insurers to dispense specialty drugs.

SPARTANBURG, S.C. – Pharmacy technology provider QS/1 has entered a contract with CoverMyMeds to automate a process often required by insurers to dispense specialty drugs.

QS/1 said it entered a partnership with CoverMyMeds to automate the prior-authorization process, required for 90% of specialty drugs on the market.

"A pharmacist can spend a lot of time cutting through the red tape to get these prescriptions filled," QS/1 pharmacy market analyst John Frady said. "CoverMyMeds helps cut down on that work load by automating the process."

December 3, 2012

Specialty pharmacy purchasing and channel management group Armada Health Care and healthcare services company Amerinet will provide services to each other's members under a co-marketing agreement, the two companies said Monday.

NEW YORK — Specialty pharmacy purchasing and channel management group Armada Health Care and healthcare services company Amerinet will provide services to each other's members under a co-marketing agreement, the two companies said Monday.

Amerinet members will receive access to Armada's specialty pharmacy services, while Armada will also provide members technology services, network access, limited-distribution products and others. Meanwhile, Armada members will receive Amerinet's contract portfolio of medical surgical and other non-pharmaceutical products.

December 3, 2012

Women with ovarian cancer and diabetes who took the generic diabetes drug metformin showed better survival rates than those who did not take the drug, according to a new study led by the Mayo Clinic.

NEW YORK — Women with ovarian cancer and diabetes who took the generic diabetes drug metformin showed better survival rates than those who did not take the drug, according to a new study led by the Mayo Clinic.

The study, published in the journal Cancer, enrolled 61 patients who took metformin and 178 who didn't. Of those who took the drug, 67% were surviving after five years, compared with 47% of those who didn't take it. Further analysis indicated that patients taking metformin were almost four times likelier to survive than those not taking it.

December 3, 2012

Merck has started a clinical trial that it hopes will eventually enroll 1,700 patients to evaluate an experimental drug for Alzheimer's disease, the company said.

WHITEHOUSE STATION, N.J. — Merck has started a clinical trial that it hopes will eventually enroll 1,700 patients to evaluate an experimental drug for Alzheimer's disease, the company said.

Merck announced the start of "EPOCH," a combined phase-2 and phase-3 study of the drug MK-8931, a 78-week trial in which patients will take either the drug in the 12-mg, 40-mg or 60-mg doses or placebo.

December 3, 2012

Rite Aid is offering a $5 discount on flu vaccinations through the middle of this month, the retail pharmacy chain said Monday.

CAMP HILL, Pa. — Rite Aid is offering a $5 discount on flu vaccinations through the middle of this month, the retail pharmacy chain said Monday.

To mark National Influenza Vaccination Week, which the Centers for Disease Control and Prevention started in 2005, which started Sunday and runs through Saturday, Rite Aid is administering flu vaccinations for $24.99 through Dec. 15. The original price was $29.99.

November 30, 2012

The Food and Drug Administration has approved a new drug made by Exelixis for treating thyroid cancer, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Exelixis for treating thyroid cancer, the agency said.

The FDA announced the approval of Cometriq (cabozatinib) to treat medullary thyroid cancer — a cancer that develops in cells in the thyroid gland that make calcitonin, a hormone that helps maintain a healthy level of calcium in the blood — that has spread to other parts of the body. Another drug to treat medullary thyroid cancer, AstraZeneca's Caprelsa (vandetanib), was approved last year.

November 30, 2012

HIV test maker OraSure Technologies has appointed a new executive to head its consumer marketing division as it prepares to launch a nationwide TV campaign on Saturday.

BETHLEHEM, Pa. — HIV test maker OraSure Technologies has appointed a new executive to head its consumer marketing division as it prepares to launch a nationwide TV campaign on Saturday.

The TV campaign will be timed to coincide with World AIDS Day on Saturday and will air on MTV, A&E, BET, E!, Bravo and Logo, as well as on the NBC reality show "The Voice" on Dec. 17.

November 30, 2012

Increasing the prescriptions filled by Medicare beneficiaries by 1% would reduce the program's spending on medical services by about 0.2% by reducing costs in such areas as hospitalizations, according to a new report by the Congressional Budget Office.

WASHINGTON — Increasing the prescriptions filled by Medicare beneficiaries by 1% would reduce the program's spending on medical services by about 0.2% by reducing costs in such areas as hospitalizations, according to a new report by the Congressional Budget Office.

November 29, 2012

The Food and Drug Administration approved a new generic drug made by Mylan for urinary disorders, the company said Thursday.

PITTSBURGH — The Food and Drug Administration approved a new generic drug made by Mylan for urinary disorders, the company said Thursday.

Mylan announced the approval and launch of tolterodine tartrate tablets in the 1-mg and 2-mg strengths. The drug is a generic version of Detrol, made by Pharmacia and Upjohn, now owned by Pfizer.

Used to treat overactive bladder, tolterodine tartrate tablets had sales of about $61.5 million during the 12-month period ended in September, according to IMS Health.

November 29, 2012

A Food and Drug Administration panel has voted to recommend approval for a Johnson & Johnson drug to treat tuberculosis while the agency has recommended accelerated approval for the drug, the company said.

RARITAN, N.J. — A Food and Drug Administration panel has voted to recommend approval for a Johnson & Johnson drug to treat tuberculosis while the agency has recommended accelerated approval for the drug, the company said.

November 29, 2012

Regional player Kinney Drugs, which operates operates 95 stores in central and northern New York and Vermont, announced on Thursday that Jim Wuest, VP marketing, plans to retire at the end of the year. 


GOUVERNEUR, N.Y. — Regional player Kinney Drugs, which operates operates 95 stores in central and northern New York and Vermont, announced on Thursday that Jim Wuest, VP marketing, plans to retire at the end of the year.  
 


Wuest joined Kinney Drugs in 2006, and has been an active member of the executive team and an influential part of the company’s success over the years. He is an industry veteran whose contributions as VP marketing have been paramount to the advancement of Kinney’s marketing and merchandising strategies, the company stated.
 

November 29, 2012

Drug companies have made "remarkable progress" in treatment options for patients with HIV and AIDS, according to two new reports from a drug industry trade group.

WASHINGTON — Drug companies have made "remarkable progress" in treatment options for patients with HIV and AIDS, according to two new reports from a drug industry trade group.

November 29, 2012

The global market for generic drugs will reach more than $125 billion next year, according to a new report by a British market-research firm.

LONDON — The global market for generic drugs will reach more than $125 billion next year, according to a new report by a British market-research firm.

November 29, 2012

The number of adults who are familiar with retail clinics and have used them has increased in recent years, according to a recent study by Kalorama Information, a publisher of healthcare market research.

NEW YORK — The number of adults who are familiar with retail clinics and have used them has increased in recent years, according to a recent study by Kalorama Information, a publisher of healthcare market research.